.Pharmacolibrary.Drugs.S_SensoryOrgans.S01L_OcularVascularDisorderAgents.S01LA01_Verteporfin.Verteporfin .Pharmacolibrary.Drugs.S_SensoryOrgans.S01L_OcularVascularDisorderAgents.S01LA01_Verteporfin.Verteporfin| name: | Verteporfin | |
| ATC code: | S01LA01 | |
| route: | intravenous | |
| compartments: | 2 | |
| dosage: | 6 | mg |
| volume of distribution: | 0.18 | L |
| clearance: | 3.29 | L/h/kg |
| other parameters in model implementation | ||
Verteporfin is a photosensitizing agent used in photodynamic therapy to treat neovascular (wet) age-related macular degeneration and pathological myopia. It is approved and used clinically for ocular neovascular conditions.
Pharmacokinetic parameters reported in adults aged 18-85 years without significant comorbidities after intravenous infusion over 10 minutes.